Hanna John Walter JR 4

What Happened

• John W. Hanna Jr., President & CEO and a director of CareDx (CDNA), exercised 118,000 option-derived shares on 2026-07-16 at $8.20 per share (cost $967,600) and then sold a total of 118,000 shares that same day in two blocks: 50,000 shares at a weighted avg $36.11 (proceeds $1,805,705) and 68,000 shares at a weighted avg $39.01 (proceeds $2,652,932). Total gross proceeds from the sales were about $4.46 million. The combination of an exercise followed by an immediate sale indicates a cashless exercise / immediate disposition of the shares acquired.

Key Details

• Transaction date: July 16, 2026; Form 4 filed July 17, 2026 (timely filing).
• Option exercise: 118,000 shares acquired at $8.20 each (total $967,600).
• Sales: 50,000 shares at weighted avg $36.11 (range $35.56–$36.51) and 68,000 shares at weighted avg $39.01 (range $39.00–$39.15); combined proceeds ≈ $4.46M.
• The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025 (per footnote).
• A separate line shows a 118,000-share derivative disposition at $0.00 (reflecting the mechanics of the option exercise/surrender); footnote on vesting: 1/4 vested April 15, 2025 and then 1/48th monthly thereafter.
• Shares owned after these transactions are not specified in the provided filing excerpt.

Context

• This is a routine executive transaction where options were exercised and the resulting shares were sold the same day — a common cashless exercise pattern that converts option value to cash for the insider and does not necessarily indicate a change in company outlook.
• The presence of a pre-established 10b5-1 plan means the sales were planned in advance and scheduled to occur irrespective of short-term insider views.